1887

Abstract

Acid suppression therapy in critically ill patients significantly reduces the incidence of stress ulceration and gastrointestinal (GI) bleeding; however, recent studies suggest that proton pump inhibitors (PPIs) increase the risk of pneumonia. We wanted to test the hypothesis that acid suppressive therapy promotes alteration in the bacterial flora in the GI tract and leads to colonization of the upper airway tract with pathogenic species, potentially forming the biological basis for the observed increased incidence of pneumonia in these patients. This was a prospective observational study on patients (adults 18 years or older) admitted to the medical intensive care unit (MICU) at a tertiary care centre. Exclusion criteria included all patients with a diagnosis of pneumonia at admission, with infection in the upper airway, or with a history of significant dysphagia. Oropharyngeal cultures were obtained on day 1 and days 3 or 4 of admission. We collected data on demographics, clinical information, and severity of the underlying disease using APACHE II scores. There were 110 patients enrolled in the study. The mean age was 49±16 years, 50 were women, and the mean APACHE II score was 9.8±6.5. Twenty per cent of the patients had used a PPI in the month preceding admission. The first oropharyngeal specimen was available in 110 cases; a second specimen at 72–96 h was available in 68 cases. Seventy-five per cent of the patients admitted to the MICU had abnormal flora. In multivariate logistic regression, diabetes mellitus and PPI use were associated with abnormal oral flora on admission. Chronic renal failure and a higher body mass index reduced the frequency of abnormal oral flora on admission. Most critically ill patients admitted to our MICU have abnormal oral flora. Patients with diabetes and a history of recent PPI use are more likely to have abnormal oral flora on admission.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.053066-0
2013-05-01
2019-10-16
Loading full text...

Full text loading...

/deliver/fulltext/jmm/62/5/778.html?itemId=/content/journal/jmm/10.1099/jmm.0.053066-0&mimeType=html&fmt=ahah

References

  1. Abele-Horn M. , Dauber A. , Bauernfeind A. , Russwurm W. , Seyfarth-Metzger I. , Gleich P. , Ruckdeschel G. . ( 1997; ). Decrease in nosocomial pneumonia in ventilated patients by selective oropharyngeal decontamination (SOD). . Intensive Care Med 23:, 187–195. [CrossRef] [PubMed]
    [Google Scholar]
  2. Al-Nowaiser A. , Roberts G. J. , Trompeter R. S. , Wilson M. , Lucas V. S. . ( 2003; ). Oral health in children with chronic renal failure. . Pediatr Nephrol 18:, 39–45. [CrossRef] [PubMed]
    [Google Scholar]
  3. Altman K. W. , Waltonen J. D. , Hammer N. D. , Radosevich J. A. , Haines G. K. III . ( 2005; ). Proton pump (H+/K+-ATPase) expression in human laryngeal seromucinous glands. . Otolaryngol Head Neck Surg 133:, 718–724. [CrossRef] [PubMed]
    [Google Scholar]
  4. Altman K. W. , Waltonen J. D. , Tarjan G. , Radosevich J. A. , Haines G. K. III . ( 2007; ). Human lung mucous glands manifest evidence of the H+/K+-ATPase proton pump. . Ann Otol Rhinol Laryngol 116:, 229–234.[PubMed] [CrossRef]
    [Google Scholar]
  5. Baker D. E. . ( 2006; ). Intravenous proton pump inhibitors. . Rev Gastroenterol Disord 6:, 22–34.[PubMed]
    [Google Scholar]
  6. Bonten M. J. , Gaillard C. A. , van der Geest S. , van Tiel F. H. , Beysens A. J. , Smeets H. G. , Stobberingh E. E. . ( 1995; ). The role of intragastric acidity and stress ulcus prophylaxis on colonization and infection in mechanically ventilated ICU patients. A stratified, randomized, double-blind study of sucralfate versus antacids. . Am J Respir Crit Care Med 152:, 1825–1834.[PubMed] [CrossRef]
    [Google Scholar]
  7. Eom C. S. , Jeon C. Y. , Lim J. W. , Cho E. G. , Park S. M. , Lee K. S. . ( 2011; ). Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis. . CMAJ 183:, 310–319. [CrossRef] [PubMed]
    [Google Scholar]
  8. Fagon J. Y. , Chastre J. , Hance A. J. , Montravers P. , Novara A. , Gibert C. . ( 1993; ). Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. . Am J Med 94:, 281–288. [CrossRef] [PubMed]
    [Google Scholar]
  9. Gulmez S. E. , Holm A. , Frederiksen H. , Jensen T. G. , Pedersen C. , Hallas J. . ( 2007; ). Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. . Arch Intern Med 167:, 950–955. [CrossRef] [PubMed]
    [Google Scholar]
  10. Johanson W. G. Jr , Seidenfeld J. J. , de los Santos R. , Coalson J. J. , Gomez P. . ( 1988; ). Prevention of nosocomial pneumonia using topical and parenteral antimicrobial agents. . Am Rev Respir Dis 137:, 265–272.[PubMed] [CrossRef]
    [Google Scholar]
  11. Khovidhunkit S. O. , Suwantuntula T. , Thaweboon S. , Mitrirattanakul S. , Chomkhakhai U. , Khovidhunkit W. . ( 2009; ). Xerostomia, hyposalivation, and oral microbiota in type 2 diabetic patients: a preliminary study. . J Med Assoc Thai 92:, 1220–1228.[PubMed]
    [Google Scholar]
  12. Laheij R. J. , Sturkenboom M. C. , Hassing R. J. , Dieleman J. , Stricker B. H. , Jansen J. B. . ( 2004; ). Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. . JAMA 292:, 1955–1960. [CrossRef] [PubMed]
    [Google Scholar]
  13. Mikawa K. , Akamatsu H. , Nishina K. , Shiga M. , Maekawa N. , Obara H. , Niwa Y. . ( 1999; ). The effects of cimetidine, ranitidine, and famotidine on human neutrophil functions. . Anesth Analg 89:, 218–224.[PubMed]
    [Google Scholar]
  14. Myles P. R. , Hubbard R. B. , McKeever T. M. , Pogson Z. , Smith C. J. , Gibson J. E. . ( 2009; ). Risk of community-acquired pneumonia and the use of statins, ACE inhibitors and gastric acid suppressants: a population-based case-control study. . Pharmacoepidemiol Drug Saf 18:, 269–275. [CrossRef] [PubMed]
    [Google Scholar]
  15. Paritpokee, S., Hall, G. & Procop, G. (2005). Rapid identification of yeast isolates using BD BBL CHROMagar Candida. 105th General Meeting of the American Society for Microbiology, Atlanta, GA, Abstract C224, Session 176.
  16. Pinducciu G. , Micheletti L. , Piras V. , Songini C. , Serra C. , Pompei R. , Pintus L. . ( 1996; ). Periodontal disease, oral microbial flora and salivary antibacterial factors in diabetes mellitus type 1 patients. . Eur J Epidemiol 12:, 631–636. [CrossRef] [PubMed]
    [Google Scholar]
  17. Prod’hom G. , Leuenberger P. , Koerfer J. , Blum A. , Chiolero R. , Schaller M. D. , Perret C. , Spinnler O. , Blondel J. et al. ( 1994; ). Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial. . Ann Intern Med 120:, 653–662.[PubMed] [CrossRef]
    [Google Scholar]
  18. Rello J. , Ollendorf D. A. , Oster G. , Vera-Llonch M. , Bellm L. , Redman R. , Kollef M. H. . VAP Outcomes Scientific Advisory Group ( 2002; ). Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. . Chest 122:, 2115–2121. [CrossRef] [PubMed]
    [Google Scholar]
  19. Robinson M. . ( 2004; ). Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors – overview and clinical implications. . Aliment Pharmacol Ther 20: (Suppl. 6), 1–10. [CrossRef] [PubMed]
    [Google Scholar]
  20. Sarkar M. , Hennessy S. , Yang Y. X. . ( 2008; ). Proton-pump inhibitor use and the risk for community-acquired pneumonia. . Ann Intern Med 149:, 391–398.[PubMed] [CrossRef]
    [Google Scholar]
  21. Selimoglu M. A. , Selimoglu E. , Kurt A. . ( 1999; ). Nasal mucociliary clearance and nasal and oral pH in patients with insulin-dependent diabetes. . Ear Nose Throat J 78:, 585–588, 590.[PubMed]
    [Google Scholar]
  22. Tablan O. C. , Anderson L. J. , Besser R. , Bridges C. , Hajjeh R. . CDC Healthcare Infection Control Practices Advisory Committee ( 2004; ). Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. . MMWR Recomm Rep 53: (RR-3), 1–36.[PubMed]
    [Google Scholar]
  23. Theisen J. , Nehra D. , Citron D. , Johansson J. , Hagen J. A. , Crookes P. F. , DeMeester S. R. , Bremner C. G. , DeMeester T. R. , Peters J. H. . ( 2000; ). Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. . J Gastrointest Surg 4:, 50–54. [CrossRef] [PubMed]
    [Google Scholar]
  24. Väkeväinen S. , Tillonen J. , Salaspuro M. , Jousimies-Somer H. , Nuutinen H. , Färkkilä M. . ( 2000; ). Hypochlorhydria induced by a proton pump inhibitor leads to intragastric microbial production of acetaldehyde from ethanol. . Aliment Pharmacol Ther 14:, 1511–1518. [CrossRef] [PubMed]
    [Google Scholar]
  25. Wang K. , Lin H. J. , Perng C. L. , Tseng G. Y. , Yu K. W. , Chang F. Y. , Lee S. D. . ( 2004; ). The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach. . Hepatogastroenterology 51:, 1540–1543. [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.053066-0
Loading
/content/journal/jmm/10.1099/jmm.0.053066-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error